Phase
Condition
Astrocytoma
Glioblastoma Multiforme
Gliomas
Treatment
FET-PET/MRI
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Each participant must meet all of the following inclusion criteria to participate in this study:
≥ 18 years of age
Diagnosis of glioblastoma multiforme
Post-maximally safe surgical resection
No prior radiation or systemic treatment for high grade glioma
Able to tolerate PET/MRI scan with intravenous contrast
Willing to provide informed consent
Exclusion
Exclusion Criteria:
All participants meeting any of the following exclusion criteria at baseline screening will be excluded from participation in this study:
MRI contraindication
Creatinine clearance < 30mL/min
Inability to lie still for 60 minutes
Gadolinium allergy
Positive pregnancy test
Breastfeeding
Patient unable to follow the protocol for any reason
Study Design
Connect with a study center
Sunnybrook Health Sciences Centre
Toronto, Ontario M4N 3M5
CanadaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.